Analyst Ranking
Bottom 4%
#4189 out of 4339 analysts
Average Return
Win Rate
18%4 out of 22
Risk vs Reward

Thomas Flaten's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Diamedica Therapeutics IncDMAC
2022-07-07 -
Strong Buy
Biolife Solutions IncBLFS
2020-02-24 -
Strong Buy
Castle Biosciences IncCSTL
2023-06-05 -
Strong Buy
Biolife Solutions IncBLFS
2023-08-09 -
Strong Buy

Thomas Flaten Analyst Color

Get additional color on Thomas Flaten's coverage of popular stocks

Thomas Flaten's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Optinose IncOPTN
1Strong Buy$3.00+140.00%Initiates Coverage On
a month ago
Checkpoint Therapeutics IncCKPT
3Strong Buy$14.00+907.19%Maintains
a month ago
Better Therapeutics IncBTTX
2Strong Buy$3.00+757.14%Maintains
2 months ago
Biolife Solutions IncBLFS
2Strong Buy$25.00+77.94%Maintains
2 months ago
Castle Biosciences IncCSTL
4Strong Buy$32.00+95.24%Reiterates
3 months ago
Achieve Life Sciences IncACHV
2Strong Buy$19.00+341.86%Maintains
4 months ago
Assertio Holdings IncASRT
2Strong Buy$9.00+242.21%Maintains
5 months ago
Evaxion Biotech AEVAX
1Strong Buy$7.00+734.33%Maintains
6 months ago
Oncocyte CorpOCX
10 months ago
Diamedica Therapeutics IncDMAC
1Strong Buy$8.00N/AMaintains
a year ago
Fresh Tracks Therapeutics IncFRTX
a year ago
Ensysce Biosciences IncENSC
1Strong Buy$960.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.